JSR Life Sciences’ Amsphere A3 Integrated into the Commercial Manufacturing of FDA-Approved Antibody Therapy
SUNNYVALE, Calif.--(BUSINESS WIRE)--JSR Life Sciences announces that its Amsphere™ A3 is being used for the first time in the commercial manufacture of an FDA-approved treatment.
